Bank of America’s Tonix Pharmaceuticals TNXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $838K | Buy |
60,958
+30,644
| +101% | +$472K | ﹤0.01% | 4611 |
|
|
2025
Q4 | $474K | Buy |
30,314
+25,663
| +552% | +$473K | ﹤0.01% | 4940 |
|
|
2025
Q3 | $112K | Buy |
4,651
+1,146
| +33% | +$42.5K | ﹤0.01% | 6551 |
|
|
2025
Q2 | $126K | Sell |
3,505
-2,255
| -39% | -$59.1K | ﹤0.01% | 6409 |
|
|
2025
Q1 | $103K | Buy |
5,760
+5,745
| +38,300% | +$116K | ﹤0.01% | 6478 |
|
|
2024
Q4 | $501 | Buy |
15
+13
| +650% | +$270 | ﹤0.01% | 7411 |
|
|
2024
Q3 | $27 | Buy |
+2
| New | +$80 | ﹤0.01% | 7923 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 8016 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 7659 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 7700 |
|
|
2023
Q3 | – | Sell |
-8
| Closed | -$29.2K | – | 7665 |
|
|
2023
Q2 | $41.7K | Buy |
+8
| New | +$60.6K | ﹤0.01% | 6520 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 7448 |
|
|
2022
Q4 | – | Sell |
-1
| Closed | -$8.63K | – | 7237 |
|
|
2022
Q3 | $11K | Sell |
1
-1
| -50% | -$24.5K | ﹤0.01% | 7210 |
|
|
2022
Q2 | $55K | Hold |
2
| – | – | ﹤0.01% | 6790 |
|
|
2022
Q1 | $327K | Sell |
2
-1
| -33% | -$153K | ﹤0.01% | 6122 |
|
|
2021
Q4 | $582K | Buy |
+3
| New | +$954K | ﹤0.01% | 5733 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6889 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 6200 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7770 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 7367 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 7174 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 7130 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 7244 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 7394 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 7501 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 7411 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 7001 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6995 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 6965 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 6989 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 6985 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 6932 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 6873 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 6843 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 6872 |
|
|
2016
Q3 | – | Hold |
0
| – | -$10K | – | 7350 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 6500 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 6337 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 6172 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 6227 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 5995 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 5850 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 6599 |
|
|
2014
Q1 | – | Hold |
0
| – | -$1K | – | 8075 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 7745 |
|
Other funds holding TNXP
VCM
JHC
Bank of America's TNXP Position: Q1 2026 in Review
Bank of America increased its Tonix Pharmaceuticals (TNXP) stake by 101% in Q1 2026, buying an estimated $472K and bringing the position to 60,958 shares worth $838K. The position accounts for ﹤0.01% of the portfolio, ranked #4611.
Bank of America first reported a position in TNXP in Q4 2021 and has held it in 12 quarters since. 81 funds tracked by Wall St. Rank hold TNXP as of Q1 2026.
- Bank of America held 60,958 shares of Tonix Pharmaceuticals worth $838K as of Q1 2026.
- Bank of America bought 30,644 Tonix Pharmaceuticals shares in Q1 2026, an estimated $472K.
- Tonix Pharmaceuticals made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4611 holding.
- Bank of America first reported a position in Tonix Pharmaceuticals in Q4 2021 and has held it in 12 quarters since.
- 81 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.